Revista: | Annals of hepatology |
Base de datos: | PERIÓDICA |
Número de sistema: | 000415640 |
ISSN: | 1665-2681 |
Autors: | Soresi, Maurizio1 Vecchi, Valentina Li1 Giannitrapani, Lydia1 Carlo, Paola Di2 Mazzola, Giovanni3 Colletti, Pietro3 Spada, Emanuele La1 Vizzini, Giovanni4 Montalto, Giuseppe1 |
Institucions: | 1Universita di Palermo, Dipartimento Biomedico di Medicina Interna, Palermo, Sicilia. Italia 2Universita di Palermo, Dipartimento di Scienze delle Promozione della Salute, Palermo, Sicilia. Italia 3Policlinico Paolo Giaccone-Palermo, Sezione di Malattie Infettive, Palermo, Sicilia. Italia 4University of Pittsburgh Medical Center, Mediterranean Institute for Transplantation and Advanced Specialized Therapies, Palermo, Sicilia. Italia |
Any: | 2013 |
Període: | Sep-Oct |
Volum: | 12 |
Número: | 5 |
Paginació: | 740-748 |
País: | México |
Idioma: | Inglés |
Tipo de documento: | Artículo |
Enfoque: | Analítico, descriptivo |
Resumen en inglés | Conflicting data have been reported on the prevalence of liver steatosis, its risk factors and its relationship with fibrosis in patients with human immunodeficiency virus (HIV)/hepatitis C virus (HCV) co-infection or with HCV mono-infection. Aim. The study aims were to assess steatosis prevalence and its risk factors in both HCV groups. We also evaluated whether steatosis was linked with advanced fibrosis. Sixty-eight HIV/HCV co-infected and 69 HCV mono-infected patients were consecutively enrolled. They underwent liver ultrasonography and transient elastography. Bright liver echo-pattern was used to diagnose steatosis; advanced fibrosis was defined as liver stiffness ≥ 9.5 kPa and FIB-4 values ≥ 3.25. The optimal stiffness cut-off according to FIB-4 ≥ 3.25 was evaluated by ROC analysis. Results. No significant difference was found in steatosis-prevalence between mono- and co-infected patients (46.3 vs. 51.4%). Steatosis was associated with triglycerides and impaired fasting glucose/diabetes in HCV mono-infected, with lipodystrophy, metabolic syndrome, total-cholesterol and triglycerides in co-infected patients. Stiffness ≥ 9.5 was significantly more frequent in co-infection (P < 0.003). Advanced fibrosis wasn’t significantly associated with steatosis. The area under the ROC curve was 0.85 (95% CI 0.79-0.9). On multivariate analysis steatosis was associated with triglycerides in both HCV mono- and co-infected groups (P < 0.02; P < 0.03). Conclusion. Although steatosis was common in both HCV mono- and co-infected patients, it was not linked with advanced fibrosis. Triglycerides were independent predictors of steatosis in either of the HCV-groups. Dietary interventions and lifestyle changes should be proposed to prevent metabolic risk factors |
Disciplines | Medicina |
Paraules clau: | Diagnóstico, Gastroenterología, VIH, Virus de la hepatitis C, Fibrosis hepática, Esteatosis, Elastografía transitoria |
Keyword: | Medicine, Diagnosis, Gastroenterology, HIV, Hepatitis C virus, Liver fibrosis, Steatosis, Transient elastography |
Text complet: | Texto completo (Ver PDF) |